| Mrs Stephanie L Mello, MA CCC SLP | |
|
124 Hammond Dr, Canton, GA 30114-6558 | |
| (678) 492-0400 | |
| (678) 493-2052 |
| Full Name | Mrs Stephanie L Mello |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 124 Hammond Dr, Canton, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144391319 | NPI | - | NPPES |
| 693050591D | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SLP006259 (Georgia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Stephanie L Mello, MA CCC SLP 303 Legacy Drive, Canton, GA 30115 Ph: (678) 492-0400 | Mrs Stephanie L Mello, MA CCC SLP 124 Hammond Dr, Canton, GA 30114-6558 Ph: (678) 492-0400 |
News Archive
Pacific Biosciences of California, Inc., today launched a new and unique solution to detect DNA base modifications associated with epigenetic regulation and DNA damage using the PacBio RS High Resolution Genetic Analyzer.
Long-term follow-up of the DIGAMI 1 trial – a landmark study of type 2 diabetes in Sweden – shows that intensive insulin treatment prolonged life by more than 2 years in patients with diabetes after a heart attack, compared with standard treatment for diabetes, reports Dr Viveca Ritsinger from the Unit of Cardiology of the Department of Medicine, Karolinska Institute, Stockholm, Sweden and colleagues in The Lancet Diabetes & Endocrinology.
Eisai Inc., the U.S. pharmaceutical operation of Tokyo-based Eisai Co., Ltd., announced today that it has entered into an agreement with Arena Pharmaceuticals GmbH, a wholly owned subsidiary of Arena Pharmaceuticals, Inc., for exclusive U.S. rights to commercialize lorcaserin, a drug candidate for potential use in the treatment of obesity, including weight loss, for patients who are obese (Body Mass Index or BMI ≥ 30) or overweight (BMI ≥ 27) with at least one weight-related co-morbid condition.
In the largest and most reliable study of its type, the University of Oxford (UK) and the University of Sydney (Australia) have demonstrated that statin therapy is not a cause of increased cancer rates and deaths. The conclusions of this study will reassure the millions of people worldwide who are taking statins to lower cholesterol levels, and clarifies earlier research that had raised concerns of a causal link.
A recent Yale study may have found a new way to fight brain cancer.
› Verified 9 days ago
Cheryl Marie Kane, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 212 Riverstone Dr, Canton, GA 30114 Phone: 770-345-7796 | |
Mrs. Katelyn Victoria Martino, CCC-M.ED. SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 115 Academy St Ste 102, Canton, GA 30114 Phone: 404-444-1521 | |
Stephanie Nicole Post, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Riverstone Dr, Canton, GA 30114 Phone: 770-345-7796 | |
Alexa Larcinese, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 150 Hospital Cir, Canton, GA 30114 Phone: 770-479-5649 | |
Carolyn Pellegrino, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12875 Cumming Hwy, Canton, GA 30115 Phone: 770-240-0163 Fax: 770-240-0163 | |
Christina L Liming, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12875 Cumming Hwy Ste 104, Canton, GA 30115 Phone: 770-240-0163 Fax: 770-240-0163 |